ストックスクリーナーアプリを入手
2.23
1.76%
-0.04
Rafael Holdings Inc (RFL) 最新ニュース
12 Health Care Stocks Moving In Wednesday's After-Market Session - Benzinga
EDGAR Filing Documents for 0001213900-26-076411 - SEC.gov
Rafael Holdings: Phase 3 LPLV complete; NDA submission and topline expected 2H 2026 - TradingView
Rafael Holdings (RFL) details late-stage Trappsol Cyclo program and 2026 NDA plans - Stock Titan
RFL Q1 2025 Earnings: Net Loss of $0.37 Per Share, Stock Declines 15%Profit Cycle Analysis - dars.gov.et
Innoviz appoints former Rafael defense CEO to board - Investing.com UK
Rafael Holdings Inc. (RFL) Q1 2025 Earnings: Wider-than-Expected Loss and Absent Revenue Trigger Sharp Share DeclineSpecial Dividend Alert - dars.gov.et
Lopez Holdings keeps investors in the dark on board slate as family war heats up - Bilyonaryo Business News
Dubai-based OSN Group proposes full ownership of Abu Dhabi-headquartered Anghami - MSN
OSN seeks full ownership of Anghami in proposed take-private deal - Wamda
ANGHAMI CONFIRMS RECEIPT OF PRELIMINARY, NON-BINDING GOING-PRIVATE PROPOSAL FROM CONTROLLING SHAREHOLDER, OSN STREAMING LIMITED; ANNOUNCES APPOINTMENT OF INDEPENDENT DIRECTORS AND FORMATION OF - Lelezard
Anghami Inc. Announces Board and Committee Change - marketscreener.com
ETFs Investing in Rafael Holdings, Inc. Class B Stocks - TradingView
Rafael Holdings: The Second Half Of Calendar 2026 Could Define This Company Forever - Seeking Alpha
Price to earnings forward of Rafael Holdings, Inc. – NYSE:RFL - TradingView
Enterprise value to EBITDA forward of Rafael Holdings, Inc. – NYSE:RFL - TradingView
Price to sales forward of Rafael Holdings, Inc. – NYSE:RFL - TradingView
Form 4 Rafael Holdings Inc Class B For: 23 June - Investing.com UK
Form 4 Rafael Holdings Inc Class B For: 23 June By Investing.com - Investing.com Canada
Tax withholding trims Rafael Holdings (NYSE: RFL) CFO share position - Stock Titan
Rafael Holdings Inc (RFL) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Rafael Holdings Q1 2025 Earnings: Development Stage Loss of -$0.37; Shares Rise 3.8%Earnings Deceleration Risk - Město Břeclav
Rafael Holdings Inc (RFL) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Rafael Holdings Inc (RFL) Valuation: PE, PB & Fair Value Analysis - TradingKey
Rafael Holdings Inc (RFL) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Rafael Holdings Inc (RFL) Institutional Confidence - TradingKey
Rafael Holdings Inc (RFL) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Rafael Holdings Inc (RFL) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Rafael Holdings Inc (RFL) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Rafael Holdings Inc (RFL) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Rafael Holdings (RFL) CEO granted Class B shares with tax withholding update - Stock Titan
RFL Q1 2025 Earnings: Net Loss of $0.37 Per Share, Stock Rises 5.66%Earnings Beat Alert - newsline.com
RFL Q1 2025 Earnings: Loss Per Share of -$0.37 as Stock Rises 5.66%Net Income Trends - newsline.com
RFL Q1 2025 Earnings: Net Loss of $0.37 per Share as Holding Company Maintains Strategic FocusMargin Expansion Trends - newsline.com
Rafael Holdings Releases Q3 2026 Financial Results - AlphaStreet
Rafael Flat on Q3 Figures - TradingView
Rafael Holdings narrows Q3 loss to $(0.08) per share - scanx.trade
Rafael Holdings, Inc. 3Q 2026: Revenue $179K, EPS ($0.08) — 10-Q Summary - TradingView
RFL: Net loss widened to $20.5M on $630K revenue, with key clinical milestones expected in late 2026 - TradingView
Rafael Holdings (NYSE: RFL) posts Q3 2026 loss as it funds Trappsol Cyclo trial - Stock Titan
Rafael Holdings reports Q3 FY2026 net loss of $4.2M; cash $30.5M; NDA expected H2 2026 - TradingView
RFL: Pivotal Phase 3 trial completed; NDA submission and commercial transition expected in H2 2026 - TradingView
[8-K] Rafael Holdings, Inc. Reports Material Event - Stock Titan
Rafael Holdings Reports Third Quarter Fiscal 2026 Financial Results - The Manila Times
Rafael Holdings, Inc. Reports Q3 Fiscal 2026 Financial Results and Progress on Phase 3 TransportNPC™ Trial - Quiver Quantitative
BRIEF-Rafael Holdings Q3 Net Income USD -2.899 Million - TradingView
Rare disease trial milestone: Rafael plans 2026 NPC drug filing - Stock Titan
Rafael Holdings (RFL) completes Phase 3 TransportNPC trial - grafa.com
Rafael Holdings, Inc. Announces Completion Of Last Patient Last Visit For Pivotal Phase 3 TransportNPC Study Evaluating Trappsol Cyclo For The Treatment Of Niemann-Pick Disease Type C - marketscreener.com
Rafael Holdings Completes Pivotal Phase 3 TransportNPC Study - TipRanks
Rafael Holdings completes phase 3 NPC disease trial enrollment - Investing.com
Phase 3 NPC study completion positions Rafael (NYSE: RFL) for NDA filing - Stock Titan
Rafael Holdings completes phase 3 NPC disease trial enrollment By Investing.com - Investing.com Canada
Rafael Holdings Announces Completion of Last Patient Last Visit for Pivotal Phase 3 TransportNPC™ Study Evaluating Trappsol® Cyclo™ for the Treatment of Niemann-Pick Disease Type C - The Manila Times
Rafael Holdings Announces Completion of Last Patient Last Visit for Pivotal Phase 3 ... - Enidnews.com
Rafael Holdings Nears Finish Line in Rare Disease Race, Eyes Commercial Future - BriefGlance
Rafael Holdings concludes Phase 3 TransportNPC™ trial for NPC - grafa.com
12 Health Care Stocks Moving In Tuesday's Intraday SessionADITXT INC by Aditxt, Inc. (OTC:ADTX), AIM I - Benzinga
RFL Q1 2025 Earnings: Net Loss Reported as Company Advances Strategic InitiativesQuarterly Earnings - newsline.com
Rafael Holdings (RFL) Surges 5% as Momentum Builds; Key Resistance in SightStop Hunt - newsline.com
1.47%
0.07%
大文字化:
|
ボリューム (24 時間):